Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06846853 · ClinicalTrials.gov registry record · Phase 4
Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)
A Phase 4 study of Contrast Enhanced Images vs. Non-contrast Images and Gadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images, sponsored by UConn Health.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06846853 is a Phase 4 study of Contrast Enhanced Images vs. Non-contrast Images and Gadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images that is actively recruiting participants, run by UConn Health. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06846853, a Phase 4 study of Contrast Enhanced Images vs. Non-contrast Images and Gadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images, is actively recruiting participants, sponsored by UConn Health.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the efficacy and safety of Gadopiclenol, an FDA-approved contrast agent, for visualizing pituitary lesions on MR images by comparing with the comparator, Gadobutrol, a clinically widely used contrast agent. The study is double-blinded, so neither the participants nor the researchers know which contrast agent is being used during each scan to avoid the bias of results.
Conditions Studied
Interventions
- DRUG Gadopiclenol
- DRUG Gadobutrol (Gadavist, BAY86-4875)
Study Locations (1)
Connecticut
- University of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2025-12-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06846853
The ClinicalTrials.gov registry entry for NCT06846853 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Contrast Enhanced Images vs. Non-contrast Images appearing as the primary indexed condition, and to 2 interventions - of which Gadopiclenol is the first listed.
NCT06846853 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06846853 about?
NCT06846853 is a clinical study titled "Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)". This study will evaluate the efficacy and safety of Gadopiclenol, an FDA-approved contrast agent, for visualizing pituitary lesions on MR images by comparing with the comparator, Gadobutrol, a clinically widely used contrast agent. The study is double-blinded, so neither the participants nor the res...
What is the current status of trial NCT06846853?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2025-03-01. Estimated completion is 2025-12-25.
What conditions does trial NCT06846853 study?
This clinical trial studies the following conditions: Contrast Enhanced Images vs. Non-contrast Images, Gadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images.
What interventions are being tested in trial NCT06846853?
The interventions under investigation include: Gadopiclenol (DRUG), Gadobutrol (Gadavist, BAY86-4875) (DRUG).
Who is sponsoring clinical trial NCT06846853?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06846853 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Contrast Enhanced Images vs. Non-contrast Images
All registered trials for this condition
Gadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images
All registered trials for this condition
Connecticut
All trials with a study site in Connecticut
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.